A
Adverum Biotechnologies (ADVM)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Adverum Biotechnologies (ADVM)
Adverum Biotechnologies, Inc. operates as a biotechnology company. The Company focuses on targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitrea... Read more
- USD7.12
- USD7.64
- USD7.12
- USD29.70
- 2.50%
- --
- 136.13k
- 148.16k
- 150M
- 6.38
- -54.60%
Stock News
28 minutes ago
Insurance giant CEO shares the No. 1 piece of career advice that helped her get ahead—it's 'especially' important right now
CNBC
29 minutes ago
Bond spreads for ‘Magnificent Seven’ tighten as investors celebrate interest-rate cut
MarketWatch
30 minutes ago
Don't let Abbott Labs' litigation overhang keep you out of the stock
CNBC
43 minutes ago
Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
